Clinical Trial Update: Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain Tumors [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intraventricular methotrexate and etoposide infusions in children with recurrent posterior fossa brain tumors. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Posterior Fossa Brain Tumor

Drugs mentioned

• Etoposide (Etoposide)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Brain Tumor Recurrent | EARLY_Phase 1 | Status: COMPLETED